Resveratrol and stroke: From chemistry to medicine

Current Neurovascular Research

Volumn 11, Issue 4, 2014, Pages 390-397

  Nabavi, Seyed Fazel ^a   Li, Huige ^b   Daglia, Maria ^c   Nabavi, Seyed Mohammad ^a  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c UNIVERSITY OF PAVIA   (Italy)

Author keywords

Antioxidants; Neuroprotection; Oxidative stress; Polyphenol; Resveratrol; Stroke

Indexed keywords

RESVERATROL; ANTIOXIDANT; STILBENE DERIVATIVE;

ANTIDIABETIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG METABOLISM; DRUG STRUCTURE; EXPERIMENTAL STROKE; HEART PROTECTION; HUMAN; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; ANIMAL; BIOAVAILABILITY; CHEMISTRY; STROKE;

ANIMALS; ANTIOXIDANTS; BIOLOGICAL AVAILABILITY; HUMANS; STILBENES; STROKE;

EID: 84925776720     PISSN: 15672026     EISSN: 18755739     Source Type: Journal    
DOI: 10.2174/1567202611666140912114833     Document Type: Article

References (78)

1. Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics-2010 update A report from the American Heart Association. Circulation 2010; 121(7): e46-e215
2. Jia Q, Zheng H, Zhao X, et al. Abnormal Glucose Regulation in Patients With Acute Stroke Across China Prevalence and Baseline Patient Characteristics. Stroke 2012; 43 (3): 650-57
3. Addo J, Ayerbe L, Mohan KM, et al. Socioeconomic status and stroke an updated review. Stroke 2012; 43 (4): 1186-91
4. Kim JS, Nah H-W, Park SM, et al. Risk Factors and Stroke Mechanisms in Atherosclerotic Stroke Intracranial Compared With Extracranial and Anterior Compared With Posterior Circulation Disease. Stroke 2012; 43 (12): 3313-18
5. von Sarnowski B, Putaala J, Grittner U, et al. Lifestyle risk factors for ischemic stroke and transient ischemic attack in young adults in the Stroke in Young Fabry Patients study. Stroke 2013; 44 (1): 119-25
6. Nabavi S, Turner A, Dean O, Sureda A, Nabavi S. Post-Stroke Depression Therapy: Where are we Now? Current neurovascular research 2014
7. Nabavi S, Daglia M, Moghaddam A, Nabavi S, Curti V. Tea Consumption and Risk of Ischemic Stroke: a Brief Review of the Literature. Current pharmaceutical biotechnology 2014
8. Kaur H, Prakash A, Medhi B. Drug Therapy in Stroke: From Preclinical to Clinical Studies. Pharmacology 2013; 92 (5-6): 324-34
9. Rodriguez-Rodriguez A, Jose Egea-Guerrero J, Murillo-Cabezas F, Carrillo-Vico A. Oxidative stress in traumatic brain injury. Current medicinal chemistry 2014; 21(10): 1201-11
10. Radermacher KA, Wingler K, Langhauser F, et al. Neuroprotection after stroke by targeting NOX4 as a source of oxidative stress. Antioxidants & redox signaling 2013; 18 (12): 1418-27
11. Allen C, Bayraktutan U. Oxidative stress and its role in the pathogenesis of ischaemic stroke. International journal of stroke 2009; 4 (6): 461-70
12. Green AR, Shuaib A. Therapeutic strategies for the treatment of stroke. Drug discovery today 2006; 11(15): 681-93
13. Kelly PJ, Morrow JD, Ning M, et al. Oxidative Stress and Matrix Metalloproteinase-9 in Acute Ischemic Stroke The Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) Study. Stroke 2008; 39 (1): 100-04
14. Nabavi SF, Nabavi SM, N Setzer W, Nabavi SA, Nabavi SA, Ebrahimzadeh MA. Antioxidant and antihemolytic activity of lipidsoluble bioactive substances in avocado fruits. Fruits 2013; 68(03): 185-93
15. Alinezhad H, Azimi R, Zare M, et al. Antioxidant and Antihemolytic Activities of Ethanolic Extract of Flowers, Leaves, and Stems of Hyssopus officinalis L. Var. angustifolius. International Journal of Food Properties 2013; 16 (5):1169-78
16. Nabavi SF, Nabavi SM, Moghaddam AH, Naqinezhad A, Bigdellou R, Mohammadzadeh S. Protective effects of Allium paradoxum against gentamicin-induced nephrotoxicity in mice. Food & function 2012; 3 (1): 28-29
17. Nabavi SF, Nabavi SM, Ebrahimzadeh MA, Jafari N, Yazdanpanah S. Biological Activities of Freshwater Algae, Spirogyra singularis Nordstedt. Journal of Aquatic Food Product Technology 2013; 22(1): 58-65
18. Nabavi SF, Nabavi SM, Ebrahimzadeh MA, Eslami B, Jafari N. In Vitro Antioxidant and Antihemolytic Activities of Hydroalcoholic Extracts of Allium scabriscapum Boiss. & Ky. Aerial Parts and Bulbs. International Journal of Food Properties 2013; 16(4): 713-22
19. Curti V, Capelli E, Boschi F, et al. Modulation of human miR-17-3p expression by methyl 3-O-methyl gallate as explanation of its in vivo protective activities. Molecular nutrition & food research 2014
20. Nabavi SF, Nabavi SM, Habtemariam S, et al. Hepatoprotective effect of gallic acid isolated from Peltiphyllum peltatum against sodium fluoride-induced oxidative stress. Industrial Crops and Products 2013; 44:50-55
21. Nabavi SF, Daglia M, Moghaddam AH, Habtemariam S, Nabavi SM. Curcumin and Liver Disease: from Chemistry to Medicine. Comprehensive Reviews in Food Science and Food Safety 2014; 13(1): 62-77
22. Nabavi SF, Nabavi SM, Mirzaei M, Moghaddam AH. Protective effect of quercetin against sodium fluoride induced oxidative stress in rat's heart. Food & function 2012; 3(4): 437-41
23. Nabavi SM, Nabavi SF, Eslami S, Moghaddam AH. In vivo protective effects of quercetin against sodium fluoride-induced oxidative stress in the hepatic tissue. Food Chemistry 2012; 132(2): 931-35
24. Olas B, Wachowicz B. Resveratrol, a phenolic antioxidant with effects on blood platelet functions. Platelets 2005; 16(5): 251-60
25. Renaud Sd, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. The Lancet 1992; 339(8808): 152-326
26. Constant J. Alcohol, ischemic heart disease, and the French paradox. Clinical cardiology 1997; 20(5): 420-24
27. Hung L-M, Chen J-K, Huang S-S, Lee R-S, Su M-J. Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes. Cardiovascular research 2000; 47(3): 549-55
28. Jang M, Pezzuto J. Cancer chemopreventive activity of resveratrol. Drugs under experimental and clinical research 1998; 25(2-3): 65-77
29. Mahal H, Mukherjee T. Scavenging of reactive oxygen radicals by resveratrol: antioxidant effect. Research on chemical intermediates 2006; 32(1): 59-71
30. Athar M, Back JH, Kopelovich L, Bickers DR, Kim AL. Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms. Archives of biochemistry and biophysics 2009; 486(2): 95-102
31. Athar M, Back JH, Tang X, et al. Resveratrol: a review of preclinical studies for human cancer prevention. Toxicology and applied pharmacology 2007; 224(3): 274-83
32. Szkudelska K, Szkudelski T. Resveratrol, obesity and diabetes. European journal of pharmacology 2010; 635(1): 1-8
33. Alarcón de la Lastra C, Villegas I. Resveratrol as an anti-inflammatory and anti-aging agent: Mechanisms and clinical implications. Molecular nutrition & food research 2005; 49(5): 405-30
34. R Neves A, Lucio M, LC Lima J, Reis S. Resveratrol in medicinal chemistry: a critical review of its pharmacokinetics, drug-delivery, and membrane interactions. Current medicinal chemistry 2012; 19(11): 1663-81
35. Lattanzio V, Lattanzio VM, Cardinali A. Role of phenolics in the resistance mechanisms of plants against fungal pathogens and insects. Phytochemistry: Advances in research 2006; 661: 23-67
36. Romero-Pérez AI, Lamuela-Raventós RM, Andrés-Lacueva C, de la Torre-Boronat MC. Method for the quantitative extraction of resveratrol and piceid isomers in grape berry skins. Effect of powdery mildew on the stilbene content. Journal of Agricultural and Food Chemistry 2001; 49(1): 210-15
37. Frémont L. Biological effects of resveratrol. Life sciences 2000; 66(8): 663-73
38. He S, Jiang L, Wu B, Li C, Pan Y. Chunganenol: an unusual antioxidative resveratrol hexamer from Vitis chunganensis. The Journal of organic chemistry 2009; 74(20): 7966-69
39. Trela BC, Waterhouse AL. Resveratrol: isomeric molar absorptivities and stability. Journal of Agricultural and Food Chemistry 1996; 44(5): 1253-57
40. Lamuela-Raventos RM, Romero-Perez AI, Waterhouse AL, De La Torre-Boronat MC. Direct HPLC analysis of cis-and transresveratrol and piceid isomers in Spanish red Vitis vinifera wines. Journal of Agricultural and Food Chemistry 1995; 43(2): 281-83
41. Bishayee A, Politis T, Darvesh AS. Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma. Cancer treatment reviews 2010; 36(1):43-53
42. Rimando AM, Kalt W, Magee JB, Dewey J, Ballington JR. Resveratrol, pterostilbene, and piceatannol in vaccinium berries. Journal of agricultural and food chemistry 2004; 52(15): 4713-19
43. Regev-Shoshani G, Shoseyov O, Bilkis I, Kerem Z. Glycosylation of resveratrol protects it from enzymic oxidation. Biochem J 2003; 374: 157-63
44. Wallerath T, Deckert G, Ternes T, et al. Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 2002; 106(13): 1652-58
45. Sotheeswaran S, Pasupathy V. Distribution of resveratrol oligomers in plants. Phytochemistry 1993; 32(5): 1083-92
46. Kimura Y, Okuda H. Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice. The Journal of nutrition 2001; 131(6): 1844-49
47. Burns J, Yokota T, Ashihara H, Lean ME, Crozier A. Plant foods and herbal sources of resveratrol. Journal of Agricultural and Food Chemistry 2002; 50(11): 3337-40
48. Chen H, Tuck T, Ji X, et al. Quality assessment of Japanese Knotweed (Fallopia japonica) grown on Prince Edward Island as a source of resveratrol. Journal of agricultural and food chemistry 2013; 61(26): 6383-92
49. Yao C-S, Lin M, Liu X, Wang Y-H. Stilbene derivatives from Gnetum cleistostachyum. Journal of Asian natural products research 2005; 7(2): 131-37
50. Kobayashi S, Ding C, Nakamura Y, Nakajima I, Matsumoto R. Kiwifruits (Actinidia deliciosa) transformed with a Vitis stilbene synthase gene produce piceid (resveratrol-glucoside). Plant Cell Reports 2000; 19(9): 904-10
51. Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer research 2004; 24(5A): 2783-840
52. Ross JA, Kasum CM. Dietary flavonoids: bioavailability, metabolic effects, and safety. Annual review of Nutrition 2002; 22(1): 19-34
53. Lim C-G, AG Koffas M. Bioavailability and recent advances in the bioactivity of flavonoid and stilbene compounds. Current Organic Chemistry 2010; 14(16): 1727-51
54. Manach C, Scalbert A, Morand C, Rémésy C, Jiménez L. Polyphenols: food sources and bioavailability. The American journal of clinical nutrition 2004; 79(5): 727-47
55. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nature reviews Drug discovery 2006; 5(6): 493-506
56. Goldberg DM, Yan J, Soleas GJ. Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clinical biochemistry 2003; 36(1): 79-87
57. Pirola L, Fröjdö S. Resveratrol: one molecule, many targets. IUBMB life 2008; 60(5): 323-32
58. Wenzel E, Somoza V. Metabolism and bioavailability of trans-resveratrol. Molecular nutrition & food research 2005; 49(5): 472-81
59. Amri A, Chaumeil J, Sfar S, Charrueau C. Administration of resveratrol: what formulation solutions to bioavailability limitations? Journal of Controlled Release 2012; 158(2): 182-93
60. Singh N, Agrawal M, Doré S. Neuroprotective properties and mechanisms of resveratrol in in vitro and in vivo experimental cerebral stroke models. ACS chemical neuroscience 2013; 4(8): 1151-62
61. Saleh MC, Connell BJ, Rajagopal D, et al. Co-administration of resveratrol and lipoic acid, or their synthetic combination, enhances neuroprotection in a rat model of ischemia/reperfusion. PloS one 2014; 9(1): e87865
62. Clark D, Tuor UI, Thompson R, et al. Protection against recurrent stroke with resveratrol: endothelial protection. PloS one 2012; 7(10): e47792
63. Xia N, Daiber A, Habermeier A, et al. Resveratrol reverses endothelial nitric-oxide synthase uncoupling in apolipoprotein E knockout mice. Journal of Pharmacology and Experimental Therapeutics 2010; 335(1): 149-54
64. Li H, Xia N, Förstermann U. Cardiovascular effects and molecular targets of resveratrol. Nitric Oxide 2012; 26(2): 102-10
65. Xia N, Förstermann U, Li H. Resveratrol as a Gene Regulator in the Vasculature. Current pharmaceutical biotechnology 2014; 15(4): 401-408
66. Rege SD, Kumar S, Wilson DN, et al. Resveratrol protects the brain of obese mice from oxidative damage. Oxidative medicine and cellular longevity 2013; 2013
67. Prabhakar O. Cerebroprotective effect of resveratrol through antioxidant and anti-inflammatory effects in diabetic rats. Naunyn-Schmiedeberg's archives of pharmacology 2013; 386(8): 705-10
68. Ren J, Fan C, Chen N, Huang J, Yang Q. Resveratrol pretreatment attenuates cerebral ischemic injury by upregulating expression of transcription factor Nrf2 and HO-1 in rats. Neurochemical research 2011; 36(12): 2352-62
69. Bi XL, Yang JY, Dong YX, et al. Resveratrol inhibits nitric oxide and TNF-α production by lipopolysaccharide-activated microglia. International immunopharmacology 2005; 5(1): 185-93
70. Bureau G, Longpré F, Martinoli MG. Resveratrol and quercetin, two natural polyphenols, reduce apoptotic neuronal cell death induced by neuroinflammation. Journal of neuroscience research 2008; 86(2): 403-10
71. Shin JA, Lee H, Lim Y-K, Koh Y, Choi JH, Park E-M. Therapeutic effects of resveratrol during acute periods following experimental ischemic stroke. Journal of neuroimmunology 2010; 227(1):93-100
72. Shin JA, Lee K-E, Kim H-S, Park E-M. Acute resveratrol treatment modulates multiple signaling pathways in the ischemic brain. Neurochemical research 2012; 37(12): 2686-96
73. Wang Q, Xu J, Rottinghaus GE, et al. Resveratrol protects against global cerebral ischemic injury in gerbils. Brain research 2002; 958(2): 439-47
74. Inoue H, Jiang X-F, Katayama T, Osada S, Umesono K, Namura S. Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferator-activated receptor α in mice. Neuroscience Letters 2003; 352(3): 203-06
75. Lanzillotta A, Pignataro G, Branca C, et al. Targeted acetylation of NF-kappaB/RelA and histones by epigenetic drugs reduces postischemic brain injury in mice with an extended therapeutic window. Neurobiology of disease 2013; 49: 177-89
76. Li Z, Pang L, Fang F, et al. Resveratrol attenuates brain damage in a rat model of focal cerebral ischemia via up-regulation of hippocampal Bcl-2. Brain research 2012; 1450: 116-24
77. Yousuf S, Atif F, Ahmad M, et al. Resveratrol exerts its neuroprotective effect by modulating mitochondrial dysfunctions and associated cell death during cerebral ischemia. Brain research 2009; 1250: 242-53
78. Wang LM, Wang YJ, Cui M, et al. A dietary polyphenol resveratrol acts to provide neuroprotection in recurrent stroke models by regulating AMPK and SIRT1 signaling, thereby reducing energy requirements during ischemia. European Journal of Neuroscience 2013; 37(10): 1669-81.